| Planar imaging pattern |  | P value |
---|---|---|---|
 | Diffuse (n = 33) | Non-diffuse (n = 18) |  |
Age (mean +/− SD) | 43 +/− 16 | 49 +/− 11 | 0.16 |
Sex | |||
 M | 22 (67 %) | 10 (56 %) | 0.43 |
 F | 11 (33 %) | 8 (44 %) |  |
Indication | |||
 Haemophilia | 19 (58 %) | 6 (33 %) | 0.10 |
 Non-haemophilia | 14 (42 %) | 12 (67 %) |  |
Clinical response | |||
 Overall response (CCI ≥ 6) | 8 (24 %) | 6 (33 %) | 0.49 |
 Median CCI | 2 (0.9–7.1) | 4 (1.0–5.3) | 0.40 |
CCI classification | |||
 0–4 | 22 (67 %) | 11 (61 %) | 0.90 |
 4–8 | 9 (27 %) | 5 (28 %) |  |
 8–12 | 2 (6 %) | 2 (11 %) |  |
Improvement in clinical variables | |||
 VAS | 3 (9 %) | 4 (22 %) | 0.23 |
 Disability | 20 (61 %) | 11 (61 %) | 0.97 |
 Tenderness | 15 (45 %) | 11 (61 %) | 0.29 |
 Effusion (n = 45) | 14 (50 %) | 6 (35 %) | 0.34 |
 Swelling (n = 47) | 6 (21 %) | 4 (22 %) | 1.00 |
 Patient assessment | 10 (30 %) | 8 (44 %) | 0.31 |
 Clinician assessment | 14 (42 %) | 10 (56 %) | 0.37 |
Extra-articular Y-90 activity | 0 (0Â %) | 3 (17Â %) | 0.04 |
Nodal leak | 0 (0Â %) | 2 (11Â %) | 0.12 |
Systemic leak | 0 (0Â %) | 0 (0Â %) | 1.00 |